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A bs tr ac t
Background
Idiopathic pulmonary fibrosis is progressive and often fatal; causes of familial clus-
tering of the disease are unknown. Germ-line mutations in the genes hTERT and 
hTR, encoding telomerase reverse transcriptase and telomerase RNA, respectively, 
cause autosomal dominant dyskeratosis congenita, a rare hereditary disorder as-
sociated with premature death from aplastic anemia and pulmonary fibrosis.
Methods
To test the hypothesis that familial idiopathic pulmonary fibrosis may be caused by 
short telomeres, we screened 73 probands from the Vanderbilt Familial Pulmonary 
Fibrosis Registry for mutations in hTERT and hTR.
Results
Six probands (8%) had heterozygous mutations in hTERT or hTR; mutant telomerase 
resulted in short telomeres. Asymptomatic subjects with mutant telomerase also had 
short telomeres, suggesting that they may be at risk for the disease. We did not iden-
tify any of the classic features of dyskeratosis congenita in five of the six families.
Conclusions
Mutations in the genes encoding telomerase components can appear as familial idio-
pathic pulmonary fibrosis. Our findings support the idea that pathways leading to 
telomere shortening are involved in the pathogenesis of this disease.
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Idiopathic pulmonary fibrosis has a predictable, progressive clinical course that ultimately leads to respiratory failure. Irre-
versible fibrosis is the hallmark of the disease, 
which has a characteristic radiographic appear-
ance most often associated with the pathological 
lesion of usual interstitial pneumonia. Although 
both genetic and environmental factors have 
been implicated, the cause of idiopathic pulmo-
nary fibrosis is unknown — as, indeed, its name 
implies. Treatment approaches that target the im-
mune system have not proved to be successful.1 
From 2 to 20% of patients with idiopathic pul-
monary fibrosis have a family history of the dis-
ease; inheritance appears to be autosomal domi-
nant with variable penetrance.1-3 Aside from one 
large kindred with a mutation in the gene encod-
ing surfactant protein C in affected family mem-
bers, the genetic basis of familial forms of idio-
pathic pulmonary fibrosis is not understood.4
Telomerase is a specialized polymerase that 
adds telomere repeats to the ends of chromo-
somes.5 It has two essential components: a cata-
lytic component, telomerase reverse transcriptase 
(hTERT), and an RNA component (hTR); the latter 
provides the template for nucleotide addition by 
hTERT.6-8 The addition of telomeric repeats (a re-
peat comprising the six nucleotides — TTAGGG 
— complementary to the template in hTR) onto 
the ends of the chromosome partly offsets the 
shortening that occurs during DNA replication. 
Telomeres shorten with each cell division and ulti-
mately activate a DNA damage response that leads 
to apoptosis or cell-cycle arrest.9-13 Telomere length 
thus limits the replicative capacity of tissues and 
has been implicated in age-related disease.9-11,14,15
Dyskeratosis congenita is a rare hereditary dis-
order initially described on the basis of a triad of 
mucocutaneous manifestations: skin hyperpig-
mentation, oral leukoplakia, and nail dystrophy.16 
The most common cause of death in patients with 
dyskeratosis congenita is bone marrow failure due 
to aplastic anemia. Pulmonary disease is present 
in 20% of patients and is the second most com-
mon cause of death.16-18 The X-linked form of 
dyskeratosis congenita is severe and associated 
with mutations in the DKC1 gene.19 Autosomal 
dominant cases of dyskeratosis congenita are rare, 
can present later in adulthood, and often lack the 
classic skin manifestations. In some families, the 
hematopoietic defects develop first, implying that 
despite the originally given name, the dyskerato-
sis is not canonical.20 Heterozygous mutations in 
hTR and hTERT, the essential components of telo-
merase, underlie the genetic defect in families 
with dominant inheritance, indicating that half 
the usual dose of telomerase is inadequate for 
telomere maintenance, and tissues of high turn-
over, such as the bone marrow, are susceptible.21-24 
In autosomal dominant dyskeratosis congenita, 
anticipation can be seen in which phenotypes pre-
sent earlier and more severely in successive gener-
ations.21,24,25 This pattern implies that in these 
patients, it is not the telomerase mutation itself 
but the short telomeres that determine the sever-
ity of the disease.14,24,26
We recently identified a pedigree with autoso-
mal dominant dyskeratosis congenita that carried 
a null hTERT allele but lacked the typical muco-
cutaneous features.24 In this kindred, pulmonary 
fibrosis was dominantly transmitted and was the 
only manifestation of disease in one mutation car-
rier. The clinical presentation and pattern of fi-
brosis in this subject were typical of the idiopath-
ic form of the disease. Since familial idiopathic 
pulmonary fibrosis is also dominantly inherited, 
we hypothesized that telomere shortening causes 
this disease and that mutations in telomerase 
may contribute to it.
Me thods
Subjects
Subjects and their families were recruited into the 
Vanderbilt Familial Pulmonary Fibrosis Registry 
on the basis of the presence of two or more cases 
of idiopathic pulmonary fibrosis. (We did not 
limit families to those in which only first-degree 
relatives were affected.) Subjects were excluded 
from the study if they had a secondary cause of 
pulmonary fibrosis or if they had skin manifesta-
tions suggestive of dyskeratosis congenita. Sub-
jects were recruited from the Vanderbilt Idio-
pathic Pulmonary Fibrosis Clinic or were referred 
from other sites in North America between 1996 
and 2004. The study was approved by the local 
institutional review boards, and written informed 
consent was obtained from all subjects. Diagnos-
tic confirmation was based on a detailed clinical 
assessment (Table 1, and Table 1 of the Supple-
mentary Appendix, available with the full text 
of this article at www.nejm.org). We used the 
consensus classification of idiopathic interstitial 
pneumonia in individual cases.27 At the time the 
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registry was accessed, all 73 probands were re-
ported by their clinicians to be North Americans of 
European descent.
Sequence Analysis
Genomic DNA was isolated from peripheral blood 
with the use of standard methods. We amplified 
and sequenced hTR in both directions, as described 
previously.21 We amplified and sequenced the 16 
exons of hTERT and its 3' untranslated region with 
the use of primers listed in Table 2 of the Supple-
mentary Appendix. Amplicons of hTERT were se-
quenced in one direction, and suspected changes 
were confirmed in the opposite strand. Mutations 
in the probands and their relatives were confirmed 
by bidirectional sequencing. Sequences were in-
spected manually with the use of Sequencher soft-
ware, and variants were compared with public 
databases. Coding and noncoding variants are list-
ed in Table 3 of the Supplementary Appendix. 
Telomeres and Telomerase
A reverse-transcriptase–polymerase-chain-reaction 
(RT-PCR) assay was performed with the use of 
RNA isolated from peripheral blood to make com-
plementary DNA (cDNA). Primers were designed 
to span exons where a mutation was predicted to 
alter splicing; primer sequences are available on 
request. PCR products were cloned, and the se-
quence was verified.
The average length of telomeres was measured 
in peripheral-blood lymphocytes by flow fluores-
cence in situ hybridization (FISH), as described 
previously.28
Point mutations were generated, and the telo-
merase complex was reconstituted in vitro.24 Telo-
merase activity was assayed without amplification, 
with the use of a modified direct assay.29,30
R esult s
Mutations Affecting Telomerase Components
Of 73 probands who were screened, 6 (8%) had 
heterozygous mutations in hTERT or hTR. Five 
probands had mutations in hTERT (two missense, 
two splice junction, and one frameshift), and one 
proband had a mutation in hTR (Table 1, and 
Fig. 1 of the Supplementary Appendix). None of 
the hTERT mutations were present in 623 unaffect-
ed subjects, as determined in other studies.23,31 
Of these subjects, 140 described themselves as 
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Figure 1. Pedigrees of Six Probands with Telomerase Mutations.
Arrows point to the proband in each family, and bold italic numbers indicate subjects for whom DNA was available 
for sequencing. Subjects in whom telomere length was measured are indicated by asterisks. Mutation status is indicat-
ed by the symbols shown in the key, with squares indicating male sex and circle  indicating female sex. Deceased fami-
ly members are indicated by slashes through the symbols. In Family D, Subject DII.1 is an obligate carrier, given 
that two of his children carry the mutation and the mother does not. A total of 19 subjects with confirmed idiopath-
ic pulmonary fibrosis are included among the six families shown. The seven asymptomatic carriers in younger gen-
erations were on average 11 years younger than the probands at the time of diagnosis: 40, 44, 46, 50, 52, 55, and 68 
years of age. In Family F, three subjects had aplastic anemia, and Subject FIII.16 died from acute myeloid leukemia, 
probably in the setting of aplastic anemia. IPF denotes idiopathic pulmonary fibrosis.
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Hispanic, or Asian. The hTR mutation was also ab-
sent in 194 healthy controls. Of these subjects, 
123 described themselves as white, with the re-
maining subjects describing themselves as black, 
Hispanic, or Asian.22 
Mutations Associated with Disease and Short 
Telomeres
To determine whether telomerase mutations seg-
regated with idiopathic pulmonary fibrosis in fam-
ilies, we examined the pedigrees. The pattern of 
inheritance was consistent with autosomal dom-
inant inheritance of the disease (Fig. 1). The mu-
tant allele was present in affected subjects and 
was generally absent in asymptomatic subjects of 
the same generation. We identified mutation car-
riers who did not have symptoms of the disease. 
These subjects were on average 11 years younger 
than the probands at the time of diagnosis (Fig. 
1). This observation is consistent with the vari-
able penetrance associated with familial idio-
pathic pulmonary fibrosis and also suggests that 
the onset of disease may be age dependent.
To assess whether mutant telomerase is asso-
ciated with short telomeres, we measured the 
telomere length in lymphocytes. The average telo-
mere length was significantly less in the probands 
and asymptomatic mutation carriers than in their 
relatives who did not carry the mutation (P = 0.006) 
(Fig. 2A). A comparison of the telomere length 
in mutation carriers with that in 400 healthy con-
trols, according to age,23 showed that mutation 
carriers fell below the 10th percentile of the con-
trols (P = 0.018), whereas their relatives who were 
noncarriers clustered near the median (P = 0.575) 
(Fig. 2B). Mutant telomerase was therefore as-
sociated with short telomeres.
Impaired Activity of Mutant Telomerase
We next examined the consequences of hTERT 
and hTR mutations on telomerase function. We 
first examined the two missense mutations in 
hTERT, glutamine replacing leucine at residue 55 
(Leu55Gln) and methionine replacing threonine 
at residue 1110 (Thr1110Met). The Leu55Gln sub-
stitution identified in the proband of Family A is 
in a highly conserved region of the N-terminal; an 















































































































Figure 2. Telomere Length in Mutation Carriers and Their Relatives.
Panel A shows the average length of telomeres in lymphocytes in eight carriers and seven noncarriers of the genetic 
mutation, and Panel B shows telomere length as a function of age. The three oldest mutation carriers are the pro-
bands in Family A, Family E, and Family F. The 12 other subjects who were examined are indicated in Figure 1 by an 
asterisk. Identifiers refer to subjects from the pedigrees in Figure 1. I bars represent standard errors. Telomere 
lengths in mutation carriers were significantly less than the median value for their age (P = 0.018 by the Wilcoxon 
signed-rank test), whereas telomere lengths in noncarriers did not differ significantly from the median for their age 
(P = 0.575).
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merase RNA binding and thus the catalytic effi-
ciency of telomerase.32 The Thr1110 residue is 
also highly conserved and lies in the C-terminal 
of hTERT, a domain that is thought to mediate 
recruitment of telomerase to the telomere.33 
Both mutant versions of hTERT (Leu55Gln and 
Thr1110Met) had impaired activity, as compared 
with the wild-type enzyme (Fig. 3C and 3D). Since 
heterozygous mutations sometimes interfere with 
the function of the wild-type allele, we assayed 
the telomerase activity of a mixture of wild-type 
and mutant versions of the enzyme and observed 
no dominant negative effect (data not shown).
We also examined the effect of the hTR 98 
G→A substitution (observed in the proband of 
Family F) on telomerase activity. This mutation 
is predicted to impair base pairing in a helix in 
the essential pseudoknot domain of hTR.34 More-
over, since 98G is conserved in telomerase RNA 
in all vertebrates, a mutation at this site is expected 
to alter activity.34 When telomerase was reconsti-
tuted with the mutant hTR 98A allele, activity was 
severely impaired (Fig. 3C and 3D).
We next examined the potential consequenc-
es of the three mutations in hTERT. The deletion 
of nucleotide C at codon 112 in the proband of 
Family C leads to a frameshift mutation and is 
predicted to result in a nonfunctional, truncated 
protein. Both splice-junction mutations in Fam-
ily B and Family D occur at consensus sequences 
that are conserved in 99.9% of all eukaryotic genes 
and are therefore predicted to alter splicing. We 
examined the cDNA of primary cells from a sub-
ject in Family D who carried the IVS9-2 A→C mu-
tation and observed skipping of exon 10 but re-
tention of the reading frame (Fig. 3E). According 
to these findings, obtained by RT-PCR, synthesis 
of a protein of nearly full length is predicted. 
However, this mutant TERT is predicted to lack 
an essential motif (the C motif) in the reverse-
transcriptase domain and thus to result in a func-
tionally null protein (Fig. 3A).8
Clinical Review
We reexamined the probands for the most com-
mon features of dyskeratosis congenita. None of 
the probands had cytopenias (Table 1), and none 
had any of the classic features of dyskeratosis con-
genita at the time of diagnosis. To discern wheth-
er these six families had hidden cases of dyskera-
tosis congenita, we requeried family members and 
medical records for evidence of aplastic anemia. 
We identified no cases of aplastic anemia in five 
of the six families. In Family F, we identified 
three subjects with aplastic anemia and a fourth 
subject with probable aplastic anemia (Fig. 1). In 
this family, subjects with a hematopoietic defect 
died at a younger age (25, 26, 31, and 81 years, 
with a mean of 41 years) than did those with id-
iopathic pulmonary fibrosis (76, 70, 63, 57, 60, 
and 66 years, with a mean of 65 years). We also 
explored the possibility that asymptomatic muta-
tion carriers with short telomeres had cytopenias 
that reflected early changes of aplastic anemia. 
We examined complete blood counts in members 
of five of the families — Family A, Family B, 
Family C, Family D, and Family E — and found 
no abnormalities.
To assess whether the pulmonary fibrosis in 
the probands could be differentiated from other 
cases of idiopathic pulmonary fibrosis, we re-
viewed the clinical data. The presentation, age at 
onset, and findings on computed tomography 
were indistinguishable from those of other cases 
of the disease (Table 1 and Fig. 4). None of these 
subjects had a response to trials of immunosup-
pressive therapy. In all cases, the proband had 
Figure 3 (facing page). Biochemical Consequences  
of Telomerase Mutations in Probands.
Panel A shows conserved domains of hTERT with mis-
sense mutations, as indicated. Colors indicate con-
served domains in hTERT shared with other reverse 
transcriptases. The Leu55Gln mutation lies in the 
telomerase essential N-terminal (TEN) domain, and 
Thr1110Met is in one of four conserved C-terminal do-
mains. Panel B shows the secondary structure of hTR, 
with the site of the mutation indicated by an asterisk. 
The 98 G→A substitution lies in a critical helix of the 
pseudoknot domain, which contains the telomere tem-
plate and is responsible for binding to TERT. Panel C 
shows the telomerase activity of mutant hTERT and 
hTR alleles, as measured by the direct assay and the  
intensity and pattern of the repetitive ladder. Panel D 
shows the quantitation of telomerase activity at the 
second major band, as indicated by the arrowhead in 
Panel C. Mean activity was calculated on the basis of 
three to five experiments; the I bars represent stan-
dard errors. Panel E shows the results of an RT-PCR 
assay across exons 9 through 11 from a subject with an 
hTERT 9-2 A→C mutation, indicating that the heterozy-
gous mutation at this consensus splice junction leads 
to the skipping of exon 10. As a result, the mutant 
TERT lacks the essential motif C of the reverse-tran-
scriptase domain. 
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undergone lung biopsy, and five of the six pro-
bands had the common lesion of usual interstitial 
pneumonia. A biopsy specimen obtained from the 
sixth proband showed idiopathic interstitial pneu-
monia, not classifiable. Different idiopathic inter-
stitial pneumonia pathological lesions have been 
described in the same patient, as well as in mem-
bers of the same family with the disease, under-
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Figure 4. High-Resolution Computed Tomographic Images of the Midlung 
(Panel A through Panel D) and Bases (Panel E through Panel H) in Probands 
in Four Families.
Subject numbers are shown in the upper right-hand corners of the panels. 
In all four probands, subpleural honeycombing and increased reticular den-
sities are visible in the views at the bases. These changes extend up to the 
midlung and apexes in some subjects with more advanced stages of disease 
(e.g., Subject DIII.2).
Discussion
We have shown that mutant telomerase is associ-
ated with familial idiopathic pulmonary fibrosis, 
which suggests that the spectrum of disease 
caused by telomere shortening is more extensive 
than previously appreciated and that a subgroup 
of families with pulmonary fibrosis falls on that 
spectrum.
Short dysfunctional telomeres activate a DNA 
damage response that leads to cell death or cell-
cycle arrest. This response is manifested clini-
cally as organ failure in tissues of high turnover 
(bone marrow, skin, and gastrointestinal tract) 
in patients with, and in an animal model of, dys-
keratosis congenita.14,24 The presence of pulmo-
nary fibrosis in dyskeratosis congenita, along with 
the presence of telomerase mutations in some 
families with idiopathic pulmonary fibrosis, sug-
gests that bronchoalveolar epithelium is also con-
stantly replaced and relies on local progenitor 
reserves that are limited by short telomeres. 
On the basis of these findings, we propose 
that the fibrotic lesion in patients with short 
telomeres is provoked by a loss of alveolar cells 
rather than by a primary fibrogenic process, such 
as one that would seem to occur in autoimmune 
disease associated with lung fibrosis. This view 
is supported by the fact that misfolded surfactant 
protein C (present in affected subjects carrying 
a mutation in the corresponding gene) appears 
to be toxic to alveolar cells.4 Therefore, it is pos-
sible that in some types of fibrosis, damage of 
epithelial cells leads to a remodeling response 
that appears clinically as usual interstitial pneu-
monia. Taken together, these considerations may 
explain the lack of success in reversing idiopathic 
fibrosis with agents that modulate immune or 
inflammatory signals and support the idea that 
at least in some cases, strategies aimed at pre-
venting the loss of alveolar cells, or local respons-
es to such cell loss, may have a greater clinical 
impact.
Although mutations in the essential compo-
nents of telomerase do not seem to account for 
a majority of cases of familial pulmonary fibro-
sis, telomere shortening as a process may still 
contribute to the pathogenesis. There is evidence 
that short telomeres, rather than telomerase mu-
tations, correlate with disease in dyskeratosis 
congenita. In an animal model of dyskeratosis 
congenita, wild-type mice who inherit short telo-
meres appear to have an occult genetic disease 
and display phenotypes similar to those in mice 
that are heterozygous for mutant telomerase 
RNA.14 Acquired states that increase tissue turn-
over are also associated with short telomeres. 
One study showed that both current and former 
smokers had shorter telomeres than did age-
matched nonsmokers.36 In addition, there is some 
evidence that telomeres of the alveolar epithelium 
in smokers are shorter than those of the alveolar 
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epithelium in nonsmokers.37 It is therefore pos-
sible that somatic telomere shortening, caused by 
conditions that increase cell turnover (e.g., smok-
ing), could contribute to fibrosis. In a study 
evaluating disease onset in relatives of familial 
probands with idiopathic pulmonary fibrosis, 
cigarette smoking and older age were the stron-
gest predictors.35 Because telomere shortening 
occurs with aging and can be acquired, it may 
contribute to the disease pathogenesis even in 
persons with wild-type telomerase.
Our study will have clinical implications, as-
suming that our findings are replicated by other 
investigators. As suggested by the experience in 
aplastic anemia,23 patients who carry either hTERT 
or hTR mutations are unlikely to have a response 
to immunosuppression and may be good candi-
dates for investigational clinical trials. The pres-
ence of a diagnostic genetic test gives patients at 
risk and their clinicians a chance to consider early 
screening and evaluation tailored to identification 
of complications of dyskeratosis congenita. Pa-
tients with dyskeratosis congenita, especially those 
with severe forms, have a predisposition to can-
cers of the skin, hematopoietic system, and oral 
mucosa.
Finally, telomere length may serve as a surro-
gate marker for the identification of patients at 
greatest risk for carrying mutant telomerase genes. 
In our series of 15 subjects, longer telomeres ap-
peared to predict the absence of a telomerase mu-
tation, although this finding requires verifica-
tion in larger studies. Since the consequences of 
carrying mutant telomerase genes can appear in 
adulthood as either idiopathic pulmonary fibro-
sis or aplastic anemia without dyskeratosis, the 
consideration of such cases as part of a syndrome 
of telomere shortening may heighten the index of 
suspicion and facilitate diagnosis.
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